ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,160, issued on March 17, was assigned to University of Notre Dame du Lac (South Bend, Ind.).

"Bispecific nanoparticle systems for targeting cancer cells" was invented by Prakash Daniel Nallathamby (South Bend, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compositions and methods for targeting cancer cells and inducing cell death. In one embodiment, the composition comprises a nanoparticle system comprising a plurality of antibodies that recognize CAR-T cells and a plurality of antibodies that recognize cancer cells. The composition targets CAR-T cells to the vicinity of cancer cells, whereby upon activation, the CAR-T ce...